A novel approach to treatment of solid cancers involved therapeutic agents that inhibit the generation of new blood vessels in growing tumors

, , , , ,

On Nov. 19, 2003, a novel approach to treatment of solid cancers involved therapeutic agents that inhibit the generation of new blood vessels in growing tumors (angiogenesis).

The evidence linking tumor growth and metastases with angiogenesis is compelling: in colorectal and breast cancers, the density of microvessels in histologic specimens has been correlated with disease recurrence, metastases, and survival.

Of the identified angiogenic factors, vascular endothelial growth factor has been shown to be the most potent and specific.

Tags:


Source: Journal of the National Cancer Institute
Credit:

LifeScienceHistory.com offers three advertising package options. Each package lnclude at least two digital images for multiple page placements and maximum exposure! Rates range from just $300 to $500 per month.